Literature DB >> 17440097

Tumor necrosis factor receptor 1/c-Jun-NH2-kinase signaling promotes human neoplasia.

Jennifer Y Zhang1, Amy E Adams, Todd W Ridky, Shiying Tao, Paul A Khavari.   

Abstract

The tumor necrosis factor alpha receptor (TNFR1) activates downstream effectors that include the mitogen-activated protein kinase kinase 7 (MKK7)/c-Jun-NH(2)-kinase (JNK)/activator protein 1 (AP1) cascade. Here, we report that JNK is activated in a majority of spontaneous human squamous cell carcinomas (SCC). JNK pathway induction bypassed cell cycle restraints induced by oncogenic Ras and cooperated with Ras to convert normal human epidermis into tumors indistinguishable from SCC, confirming its oncogenic potency in human tissue. Inhibiting MKK7, JNK, and AP1 as well as TNFR1 itself using genetic, pharmacologic, or antibody-mediated approaches abolished invasive human epidermal neoplasia in a tumor cell autonomous fashion. The TNFR1/MKK7/JNK/AP1 cascade thus promotes human neoplasia and represents a potential therapeutic target for human epithelial cancers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17440097      PMCID: PMC2239246          DOI: 10.1158/0008-5472.CAN-06-4017

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

Review 1.  AP-1: a double-edged sword in tumorigenesis.

Authors:  Robert Eferl; Erwin F Wagner
Journal:  Nat Rev Cancer       Date:  2003-11       Impact factor: 60.716

2.  Oncogenic activity of Cdc6 through repression of the INK4/ARF locus.

Authors:  Susana Gonzalez; Peter Klatt; Sonia Delgado; Esther Conde; Fernando Lopez-Rios; Montserrat Sanchez-Cespedes; Juan Mendez; Francisco Antequera; Manuel Serrano
Journal:  Nature       Date:  2006-03-30       Impact factor: 49.962

3.  Expression of dominant negative c-jun inhibits ultraviolet B-induced squamous cell carcinoma number and size in an SKH-1 hairless mouse model.

Authors:  Simon J Cooper; Jacalyn MacGowan; James Ranger-Moore; Matthew R Young; Nancy H Colburn; G Tim Bowden
Journal:  Mol Cancer Res       Date:  2003-09       Impact factor: 5.852

4.  Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development.

Authors:  Caroline H Arnott; Kate A Scott; Robert J Moore; Stephen C Robinson; Richard G Thompson; Frances R Balkwill
Journal:  Oncogene       Date:  2004-03-11       Impact factor: 9.867

5.  Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation.

Authors:  Kanaga Sabapathy; Konrad Hochedlinger; Shin Yuen Nam; Anton Bauer; Michael Karin; Erwin F Wagner
Journal:  Mol Cell       Date:  2004-09-10       Impact factor: 17.970

6.  NF-kappaB RelA opposes epidermal proliferation driven by TNFR1 and JNK.

Authors:  Jennifer Y Zhang; Cheryl L Green; Shiying Tao; Paul A Khavari
Journal:  Genes Dev       Date:  2004-01-01       Impact factor: 11.361

7.  In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors.

Authors:  D J Giard; S A Aaronson; G J Todaro; P Arnstein; J H Kersey; H Dosik; W P Parks
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

Review 8.  Targeting JNK for therapeutic benefit: from junk to gold?

Authors:  Anthony M Manning; Roger J Davis
Journal:  Nat Rev Drug Discov       Date:  2003-07       Impact factor: 84.694

9.  Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.

Authors:  Arindam Dhar; Jing Hu; Raymond Reeves; Linda M S Resar; Nancy H Colburn
Journal:  Oncogene       Date:  2004-05-27       Impact factor: 9.867

10.  Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-kappaB inhibition.

Authors:  Maria H Lind; Björn Rozell; Robert P A Wallin; Max van Hogerlinden; Hans-Gustaf Ljunggren; Rune Toftgård; Inderpreet Sur
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-25       Impact factor: 11.205

View more
  26 in total

Review 1.  Current position of TNF-α in melanomagenesis.

Authors:  Iuliana Nenu; Diana Tudor; Adriana Gabriela Filip; Ioana Baldea
Journal:  Tumour Biol       Date:  2015-08-18

2.  c-Jun promotes whereas JunB inhibits epidermal neoplasia.

Authors:  Jane Y Jin; Hengning Ke; Russell P Hall; Jennifer Y Zhang
Journal:  J Invest Dermatol       Date:  2011-02-03       Impact factor: 8.551

3.  The c-Jun NH2-terminal kinase 2 plays a dominant role in human epidermal neoplasia.

Authors:  Hengning Ke; Rebecca Harris; Jonathan L Coloff; Jane Y Jin; Benjamin Leshin; Paula Miliani de Marval; Shiying Tao; Jeffrey C Rathmell; Russell P Hall; Jennifer Y Zhang
Journal:  Cancer Res       Date:  2010-03-30       Impact factor: 12.701

Review 4.  JNK signalling in cancer: in need of new, smarter therapeutic targets.

Authors:  Concetta Bubici; Salvatore Papa
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

5.  Epidermal CYLD inactivation sensitizes mice to the development of sebaceous and basaloid skin tumors.

Authors:  Yingai Jane Jin; Sally Wang; Joshua Cho; M Angelica Selim; Tim Wright; George Mosialos; Jennifer Y Zhang
Journal:  JCI Insight       Date:  2016-07-21

6.  Identification of novel Ras-cooperating oncogenes in Drosophila melanogaster: a RhoGEF/Rho-family/JNK pathway is a central driver of tumorigenesis.

Authors:  Anthony M Brumby; Karen R Goulding; Tanja Schlosser; Sherene Loi; Ryan Galea; Peytee Khoo; Jessica E Bolden; Toshiro Aigaki; Patrick O Humbert; Helena E Richardson
Journal:  Genetics       Date:  2011-03-02       Impact factor: 4.562

7.  The role of the c-Jun N-terminal Kinase signaling pathway in skin cancer.

Authors:  Jennifer Y Zhang; Maria Angelica Selim
Journal:  Am J Cancer Res       Date:  2012-11-20       Impact factor: 6.166

8.  Identification of early growth response protein 1 (EGR-1) as a novel target for JUN-induced apoptosis in multiple myeloma.

Authors:  Lijuan Chen; Siqing Wang; Yiming Zhou; Xiaosong Wu; Igor Entin; Joshua Epstein; Shmuel Yaccoby; Wei Xiong; Bart Barlogie; John D Shaughnessy; Fenghuang Zhan
Journal:  Blood       Date:  2009-10-16       Impact factor: 22.113

9.  Transcription factor regulation can be accurately predicted from the presence of target gene signatures in microarray gene expression data.

Authors:  Ahmed Essaghir; Federica Toffalini; Laurent Knoops; Anders Kallin; Jacques van Helden; Jean-Baptiste Demoulin
Journal:  Nucleic Acids Res       Date:  2010-03-09       Impact factor: 16.971

10.  Scribble mutants promote aPKC and JNK-dependent epithelial neoplasia independently of Crumbs.

Authors:  Gregory R Leong; Karen R Goulding; Nancy Amin; Helena E Richardson; Anthony M Brumby
Journal:  BMC Biol       Date:  2009-09-24       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.